South and Central America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to South & Central America In vitro diagnostics market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in South & Central America.

Scope

• The report provides information on the South and Central American in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

• Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.

• Key pipeline products that are set to shape the market, broken down by sector.

• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.

• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.

• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.

• Key mergers and acquisitions, partnerships, private equity investments and IPOs.

• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the in vitro diagnostics devices market in South and Central America.

• Evaluate and compare the attractiveness of the market in the region.

• Identify growth segments and opportunities in each industry sector within the region.

• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.

• Analyze the competitiveness of the market in the region and identify hotspots.

• Develop strategies based on the latest product, brand, expansion and research and development news in the region.

• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.

• Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

 

1

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of Markets Covered in the Report

3.1 In Vitro Diagnostics

3.2 Clinical Chemistry

3.3 Genetic Testing

3.4 Haematology

3.5 Histology And Cytology

3.6 Immuno Chemistry

3.7 Infectious Immunology

3.8 Microbiology Culture

4 In Vitro Diagnostics in South and Central America

4.1 In Vitro Diagnostics, South and Central America, Overall Revenue ($ mn), 2000-2015

4.2 In Vitro Diagnostics, South and Central America, Company share (2007-2008)

5 In Vitro Diagnostics In Brazil

5.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015

5.2 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)

5.2.1 Clinical Chemistry Distribution Share (2007-2008)

5.2.2 Genetic Testing Distribution Share (2007-2008)

5.2.3 Haematology Distribution Share (2007-2008)

5.2.4 Histology And Cytology Distribution Share (2007-2008)

5.2.5 Immuno Chemistry Distribution Share (2007-2008)

5.2.6 Infectious Immunology Distribution Share (2007-2008)

5.2.7 Microbiology Culture Distribution Share (2007-2008)

5.3 In Vitro Diagnostics, Brazil, Company Share (2007-2008)

5.3.1 In Vitro Diagnostics, Brazil, Company Share (2007-2008)

5.3.2 Clinical Chemistry, Brazil, Company Share (2007-2008)

5.3.3 Genetic Testing, Brazil, Company Share (2007-2008)

5.3.4 Haematology, Brazil, Company Share (2007-2008)

5.3.5 Histology And Cytology, Brazil, Company Share (2007-2008)

5.3.6 Immuno Chemistry, Brazil, Company Share (2007-2008)

5.3.7 Infectious Immunology, Brazil, Company Share (2007-2008)

5.3.8 Microbiology Culture, Brazil, Company Share (2007-2008)

6 In Vitro Diagnostics In Argentina

6.1 In Vitro Diagnostics, Argentina, Overall Revenue ($ mn), 2000-2015

6.2 In Vitro Diagnostics, Argentina, Distribution Share (2007-2008)

6.2.1 Clinical Chemistry Distribution Share (2007-2008)

6.2.2 Genetic Testing Distribution Share (2007-2008)

6.2.3 Haematology Distribution Share (2007-2008)

6.2.4 Histology And Cytology Distribution Share (2007-2008)

6.2.5 Immuno Chemistry Distribution Share (2007-2008)

6.2.6 Infectious Immunology Distribution Share (2007-2008)

6.2.7 Microbiology Culture Distribution Share (2007-2008)

6.3 In Vitro Diagnostics, Argentina, Company Share (2007-2008)

6.3.1 In Vitro Diagnostics, Argentina, Company Share (2007-2008)

6.3.2 Clinical Chemistry, Argentina, Company Share (2007-2008)

6.3.3 Genetic Testing, Argentina, Company Share (2007-2008)

6.3.4 Haematology, Argentina, Company Share (2007-2008)

6.3.5 Histology And Cytology, Argentina, Company Share (2007-2008)

6.3.6 Immuno Chemistry, Argentina, Company Share (2007-2008)

6.3.7 Infectious Immunology, Argentina, Company Share (2007-2008)

6.3.8 Microbiology Culture, Argentina, Company Share (2007-2008)

7 In Vitro Diagnostics In Mexico

7.1 In Vitro Diagnostics, Mexico, Overall Revenue ($ mn), 2000-2015

7.2 In Vitro Diagnostics, Mexico, Distribution Share (2007-2008)

7.2.1 Clinical Chemistry Distribution Share (2007-2008)

7.2.2 Genetic Testing Distribution Share (2007-2008)

7.2.3 Haematology Distribution Share (2007-2008)

7.2.4 Histology and Cytology Distribution Share (2007-2008)

7.2.5 Immuno Chemistry Distribution Share (2007-2008)